Ruth McKernan

Venture Partner at SV Health Investors LLP

Ruth McKernan

Ruth McKernan

Venture Partner at SV Health Investors LLP

Overview
Career Highlights

Innovate UK

RelSci Relationships

2749

Number of Boards

6

Relationships
RelSci Relationships are individuals Ruth McKernan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Vice President, BioPharmaceuticals R&D at AstraZeneca Plc

Relationship likelihood: Strong

Chief Executive Officer & Director at Medical Research Council

Relationship likelihood: Strong

Co-Founder at Alector, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at Acambis Plc

Relationship likelihood: Strong

Managing Partner at SV Health Investors LLP

Relationship likelihood: Strong

Managing Partner at SV Health Investors LLP

Relationship likelihood: Strong

Executive Chairman at Innovate UK

Relationship likelihood: Strong

Executive Chairman at Atopix Therapeutics Ltd.

Relationship likelihood: Strong

Co-Founder at AqueSys, Inc.

Relationship likelihood: Strong

Chairman at SV Health Investors LLP

Relationship likelihood: Strong

Paths to Ruth McKernan
Potential Connections via
Relationship Science
You
Ruth McKernan
Venture Partner at SV Health Investors LLP
Education

King's College London was founded by King George IV and the Duke of Wellington (then Prime Minister) in 1829 as a university college in the tradition of the Church of England. It now welcomes staff and students of all faiths and beliefs.

Memberships
Member
Current

SFN'S MISSION IS TO: 1. ADVANCE THE UNDERSTANDING OF THE BRAIN AND THE NERVOUS SYSTEM BY BRINGING TOGETHER SCIENTISTS OF DIVERSE BACKGROUNDS, BY FACILITATING THE INTEGRATION OF RESEARCH DIRECTED AT ALL LEVELS OF BIOLOGICAL ORGANIZATION, (SEE CONTINUATION ON SCHEDULE O)

Member
Current

British Pharmacological Society is a British private company located in London. The firm provides charity services to promote the spectrum of pharmacology. It was founded in 1931. Rachel Lambert-Forsyth is the current CEO of the firm.

Career History
Venture Partner
2018 - Current

SV Health Investors invests in companies located in North America and Europe. The firm targets companies operating in the fields of biotechnology, pharmaceuticals, medical devices & instruments, healthcare services. It provides financing for seed, early, later stage and buyout capital requirements.

Chief Executive Officer
2015 - 2018

Innovate UK promotes, supports and invests in technology research, development, and commercialization. The firm provides access to information about the funding and support opportunities through a range of channels. The company was founded on July 1, 2007 and is headquartered in Swindon, the United Kingdom.

Chief Scientific Officer
Prior - 2015

Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC.

Boards & Committees
Director
Current

Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC.

Director
Current

The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom.

Member, Board of Directors
Prior

Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ruth McKernan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ruth McKernan's profile does not indicate a business or promotional relationship of any kind between RelSci and Ruth McKernan.